Skip to main content

Kininase II of Human Seminal Fluid: Kinetics and Inhibition

  • Chapter
Kinins IV

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 198A))

Summary

The activity of kininase II in crude human sperm was measured continuously by measuring the hydrolysis of a blocked tripeptide 3-(2- furylacryloyl)-L- phenylalanyl-glycl-glycine (1 mmol/1). Mean seminal plasma activity was 335±6l U/g protein; the Km was 0.7 mmol/1; pH optimum was 8.8 in a 50 mmol/1 HEPES buffer and the chloride optimum was 300 mmol/1. This male genital tract enzyme is inhibited by several kininase II inhibitors. Captopril (SQ 14225) showed IC50 = 1.6 × 10−8 mol/1, with a competitive pattern (Ki = 7.3 × 10−9). 3-(Mercaptomethy1)-oxo- piperidineacetic acid showed the same kind of inhibition with an IC50 = 1.8 × 10−6 mol/1 (Ki = 6.8 × 10−7 mol/1). Enalapril diacid was the most potent inhibitor and had an IC50 of 4.1 × 10−9 mol/1 and showed a mixed competitive and non-competitive inhibition (Ki = 10−9 mol/Ki’ = 9.5 × 10−10 mol/1). These in vitro inhibition data suggest that, in vivo, such drugs may effect the function of kininase II in the male reproductive system. The observed 50% inhibition constants are comparable to those observed in lung enzyme suggesting similar kinetic properties.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. M. A. Hollinger, Serum angiotensin-converting enzyme. Status report on its diagnostic significance in pulmonary disease, Chest, 83: 589–590, (1983).

    Article  Google Scholar 

  2. D. Depierre, J. P. Bargetzi, and M. Roth, Dipeptidyl carboxypeptidase from human seminal sperm, Biochim. Biophys. Acta, 523: 469–476, (1978).

    Article  PubMed  CAS  Google Scholar 

  3. S. Kaneko, & C. Moriwaki, Studies on dipeptidyl carboxypeptddase in the male reproductive organs; its biological and pathological status J. Pharm. Dyn., 4: 175–183, (1981).

    Article  CAS  Google Scholar 

  4. S. Kaneko, & C. Moriwaki, Effects of kinins and dipeptidyl carboxypeptidase on the motility of highly washed human sperm, J. Pharm. Dyn., 4: 443–450, (1981).

    Article  CAS  Google Scholar 

  5. M. Horiuchi, K. I. Fukumura, T. Terashima, & T. Iso, Method for determination of angiotensin-converting enzyme activity in blood and tissue by high performance liquid chromatography, J. Chromatogr. 233: 123–130, (1982).

    Article  PubMed  CAS  Google Scholar 

  6. M. A. Ondetti, B. Rubin, & D. W. Cushman, Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents, Science, 166: 441–444, (1977).

    Article  Google Scholar 

  7. S. Klutcho, M. L. Hoefle, R. D. Smith, et al., Synthhsis and angio-tensin-converting enzyme inhibitory activity of 3-(mercaptomethyl)- 2-oxo-l-pyrrolidineacetic acids and 3-(mercaptomethyl)-2-oxo-l- piperidineacetic acids, J. Med. Chem., 24: 104–109, (1980).

    Article  Google Scholar 

  8. A. A. Patchett, E. Harris, E. W. Tristram, et al., A new class of angiotensin-converting enzyme inhibitors, Nature, 288: 280–283, (1980).

    Article  PubMed  CAS  Google Scholar 

  9. R. J. Klauser, C. J. G. Robinson, D. V. Marinkovic, & E. G. Erdos, Inhibition of human peptidyl dipeptidase (angiotensin-I converting enzyme: kininase II) by human serum albumin and its fragments, Hypertension, 1: 281–286, (1979).

    Article  PubMed  CAS  Google Scholar 

  10. B. Holmquist, P. Biinning, & J. F. Riordan, A continuous spectrophotometry assay for angiotensin converting enzyme, Anal. Biochem., 95: 540–548, (1979).

    Article  PubMed  CAS  Google Scholar 

  11. R. Eisenthal, & A. Cornish-Bowden, The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters, Biochem. J., 139: 715–720, (1974).

    PubMed  CAS  Google Scholar 

  12. G. L. Atkins, & I. A. Nimmo, Current trends in the estimation of Michaelis-Menten parameters, Anal. Biochem., 104: 1–9, (1980).

    Article  PubMed  CAS  Google Scholar 

  13. A. Cornish-Bowden, Principles of enzyme kinetics. Inhibitors and activators, Butterworths, London, p. 52, (1976).

    Google Scholar 

  14. R. B. Loftfield, & E. A. Eigner, Molecular order of participation of inhibitors (or activators) in biological systems, Science, 164: 305–308, (1969).

    Article  PubMed  CAS  Google Scholar 

  15. H. M. Neels, S. L. Scharpi, M. E. van Sande, & G. A. Fonteyne, Single-reagent micro centrifugal assay for antiotensin converting enzyme, Clin. Chem., 30: 163–164, (1984).

    PubMed  CAS  Google Scholar 

  16. D. W. Cushman, & H. S. Cheung, Concentrations of angiotensin converting enzyme in tissues of the rat, Biochim. Biophys. Acta, 250: 261–265, (1971).

    Article  PubMed  CAS  Google Scholar 

  17. H. M. Neels, S. L. Scharpe, G. A. Fonteyne, et al., Fluorometric assay for angiotensin converting enzyme in human serum by centrifugal analysis, Clin. Chim. Acta, 141: 281–286, (1984).

    Article  PubMed  CAS  Google Scholar 

  18. H. M. Neels, S. L. Scharpe, M. E. Van Sande, et al., Improved micro-method for assay of serum angiotensin converting enzyme, Clin. Chem., 28: 1352–1355, (1982).

    PubMed  CAS  Google Scholar 

  19. S. Ronca-Testoni, Direct spectrophotometric assay for angiotensin converting enzyme in serum, Clin. Chem., 29: 1093–1096, (1983).

    PubMed  CAS  Google Scholar 

  20. D. W. Cushman, H. S. Cheung, E. F. Sabo, & M. A. Ondetti, Design of potent competitive inhibitors of angiotensin converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl aminoacids, Biochem., 16: 5484–5491, (1977).

    Article  CAS  Google Scholar 

  21. H. Gravas, J. Biollaz, B. Waeber, et al., Effects of the oral angiotensin converting enzyme inhibitor MK-421 in human hypertension, Clin. Sci., 6: 281s–283s, (1981).

    Google Scholar 

  22. H. Sato, Components of kallikrein kinin system and treatment of male infertility, Keio J. Med., 29: 19–38, (1980).

    Article  PubMed  CAS  Google Scholar 

  23. C. Gronhagen-Riska, & F. Fyhrquist, Purification of human lung angiotensin converting snzyme, Scand. J. Clin. Lab. Invest., 40: 711–719, (1980).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

van Sande, M., Neels, H., Scharpé, S., Holmquist, B. (1986). Kininase II of Human Seminal Fluid: Kinetics and Inhibition. In: Greenbaum, L.M., Margolius, H.S. (eds) Kinins IV. Advances in Experimental Medicine and Biology, vol 198A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5143-6_63

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5143-6_63

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5145-0

  • Online ISBN: 978-1-4684-5143-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics